Molecular Diagnostics Market by Product & Service (Reagents, Kits), Test Type (Lab, PoC), Sample Type (Blood, Urine), Technology (PCR, INAAT), Application (Infectious, Oncology), End User (Diagnostic Labs, Hospitals), Region - Global Forecast to 2028

Molecular Diagnostics Market by Product & Service (Reagents, Kits), Test Type (Lab, PoC), Sample Type (Blood, Urine), Technology (PCR, INAAT), Application (Infectious, Oncology), End User (Diagnostic Labs, Hospitals), Region - Global Forecast to 2028



The molecular diagnostics market is valued at an estimated USD 16.6 billion in 2023 and is projected to reach USD 28.6 billion by 2028 at a CAGR of 11.4% during the forecast period. Diseases such as tuberculosis, HIV/AIDS, hepatitis, sexually transmitted infections, and respiratory infections require an accurate and timely diagnosis for effective treatment and control. Molecular diagnostics play a crucial role in the detection and monitoring of these infectious diseases, driving the growth of the market in this area.

Apart from infectious disease diagnostics, molecular diagnostic techniques are increasingly being used to enhance patient management, particularly in the field of cancer. The growing prevalence of cancer globally will increase the number of specimens tested, thus creating a demand for new diagnostic procedures, including molecular diagnostics.

“Blood, serum, and plasma segment accounted for the highest growth rate in the molecular diagnostics market, by sample type, during the forecast period”

The molecular diagnostics market is bifurcated into blood, serum, and plasma, urine, and other sample types on the basis of sample type. The blood, serum, and plasma segment in molecular diagnostics is experiencing substantial growth, largely driven by the increased demand for infectious disease testing. Infectious diseases pose significant global health challenges, and the accurate and timely diagnosis of these conditions is crucial for effective disease management and public health measures.

Plasma and serum samples provide several advantages for infectious disease testing. Plasma and serum samples have wide-ranging diagnostic applications in infectious diseases, including viral, bacterial, fungal, and parasitic infections. They aid in early diagnosis, appropriate treatment selection, and the assessment of treatment response. Moreover, Blood-based molecular diagnostics have demonstrated clinical utility across a broad range of applications, including genetic testing, infectious disease diagnosis, cancer diagnostics, and monitoring disease progression.

“Oncology testing segment accounted for the highest growth rate in the molecular diagnostics market, by application, during the forecast period”

The global molecular diagnostics market is bifurcated into infectious disease diagnostics, oncology testing, genetic testing, and other applications. Oncology testing segment is currently witnessing the highest growth rate within the molecular diagnostics market, reflecting the increasing importance of precision medicine and personalized approaches in cancer care. The surge in demand for oncology testing is fueled by various factors that are transforming the landscape of cancer diagnostics and treatment. Molecular diagnostic tests enable physicians to study the predisposition of genetic materials to diseases and diagnose diseases, such as cancer, at an early stage.

Through various strategic developments, pharmaceutical companies and molecular diagnostic manufacturers have increasingly focused on integrating their synergies to develop personalized medicine and companion diagnostic assays that can support the monitoring of a patient’s response to a given drug therapy. This is a major factor boosting the growth of the oncology testing segment. The growth of this segment is also driven by technological advancements and the increasing incidence of cancer.

“Asia Pacific: The fastest-growing region molecular diagnostics market”

The global molecular diagnostics market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Emerging countries in this region have witnessed growth in their GDPs and a significant rise in disposable income levels. This has led to increased healthcare spending by a larger population base, healthcare infrastructure modernization, and the rising penetration of cutting-edge clinical laboratory technologies in the Asia Pacific countries. These factors are expected to provide significant growth opportunities for molecular diagnostic companies operating in this region.

The Asia Pacific, which has become a medical tourism hub, is considered one of the fastest-growing markets for medical procedures and devices. Low infrastructure and treatment costs and the availability of highly educated physicians have driven medical tourists to these countries, which is a major factor driving the growth of the molecular diagnostics market in this region.

The break-up of the profile of primary participants in the molecular diagnostics market:

By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 – 30%

By Designation: C-level - 27%, D-level - 18%, and Others - 55%

By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6%, and Middle East & Africa- 4%

The key players in this market are F. Hoffmann-La Roche Ltd. (Switzerland), Hologic, Inc. (US), Thermo Fisher Scientific Inc. (US), Abbott Laboratories (US), bioMérieux (France), QIAGEN (Netherlands), PerkinElmer Inc. (US), Myriad Genetics, Inc. (US), Siemens Healthineers AG (Germany), Danaher (US), Illumina, Inc. (US), Becton, Dickinson and Company (US), Grifols, S.A. (Spain), QuidelOrtho Corporation (US), Agilent Technologies, Inc. (US), DiaSorin S.p.A. (Italy), Exact Sciences Corporation (US), Genetic Signatures (Australia), MDx Health (Belgium), Biocartis (Belgium), TBG Diagnostics Limited (Australia), HTG Molecular Diagnostics, Inc. (US), Vela Diagnostics (Singapore), Amoy Diagnostics Co., Ltd. (China), ELITechGroup (France), Molbio Diagnostics Pvt. Ltd. (India), Savyon Diagnostics (Israel), Abacus Diagnostica Oy (Finland), and geneOmbio Technologies Pvt. Ltd. (India).

Research Coverage:

This research report categorizes the molecular diagnostics market by product & service (reagents & kits, instruments, and services & software), test type (lab tests and PoC tests), sample type (blood, serum, and plasma, urine, and other sample types), application (infectious disease diagnostics (hepatitis, HIV, CT/NG, HAI, HPV, tuberculosis, influenza, and other infectious diseases), oncology testing (breast cancer, colorectal cancer, lung cancer, prostate cancer, and other cancer testing), genetic testing, and other applications, technology (polymerase chain reaction, isothermal nucleic acid amplification technology, DNA sequencing & next-generation sequencing, in situ hybridization, DNA microarrays, and other technologies), end user (diagnostic laboratories, hospitals & clinics, and other end users), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the molecular diagnostics market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; acquisitions, agreements. new product & service launches, and recent developments associated with the molecular diagnostics market. Competitive analysis of upcoming startups in the molecular diagnostics market ecosystem is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall molecular diagnostics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

Analysis of key drivers (increasing prevalence of infectious diseases and cancer globally, rising focus on R&D and growing funding in molecular diagnostics by healthcare-based companies, growing awareness of early disease diagnosis in developing countries, rising technological advancements in molecular diagnostics in recent years, and increasing use of PoC diagnostic tests in homecare settings and hospitals), restraints (unfavorable reimbursement scenario for diagnostic companies and high cost of molecular diagnostic instruments), opportunities (growing significance of companion diagnostics in drug development process and growth opportunities for molecular diagnostic companies in emerging economies), and challenges (changing regulatory landscape for IVD and molecular diagnostics in US and European Union, operational barriers and shortage of skills across major markets, and introduction of alternative technologies for disease detection and diagnosis) influencing the growth of the molecular diagnostics market

Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the molecular diagnostics market.

Market Development: Comprehensive information about lucrative markets – the report analyses the molecular diagnostics market across varied regions.

Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the molecular diagnostics market

Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like F. Hoffmann-La Roche Ltd. (Switzerland), Hologic, Inc. (US), Thermo Fisher Scientific Inc. (US), Abbott Laboratories (US), and bioMérieux (France), among others in the molecular diagnostics market strategies.


  • INTRODUCTION
    • STUDY OBJECTIVES
    • MARKET DEFINITION
      • INCLUSIONS AND EXCLUSIONS
    • STUDY SCOPE
      • MOLECULAR DIAGNOSTICS MARKET: MARKET SEGMENTATION
      • MOLECULAR DIAGNOSTICS MARKET: GEOGRAPHICAL SEGMENTATION
      • YEARS CONSIDERED
    • CURRENCY CONSIDERED
    • MARKET LIMITATIONS
    • STAKEHOLDERS
    • SUMMARY OF CHANGES
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
    • RESEARCH APPROACH
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION
      • BOTTOM-UP APPROACH
      • TOP-DOWN APPROACH
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • MARKET SHARE ANALYSIS
    • STUDY ASSUMPTIONS
    • RESEARCH LIMITATIONS
    • GROWTH RATE ASSUMPTIONS
    • RISK ASSESSMENT
      • RISK ASSESSMENT OF MOLECULAR DIAGNOSTICS MARKET
    • IMPACT OF ECONOMIC RECESSION ON MOLECULAR DIAGNOSTICS MARKET
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • MOLECULAR DIAGNOSTICS MARKET OVERVIEW
    • MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028
    • MOLECULAR DIAGNOSTICS MARKET, BY TEST TYPE, 2023 VS. 2028
    • MOLECULAR DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2023 VS. 2028
    • MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023 VS. 2028
    • MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2023 VS. 2028
    • MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2023 VS. 2028
    • MOLECULAR DIAGNOSTICS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
        • Table ESTIMATED NUMBER OF NEW CANCER CASES GLOBALLY, BY TYPE OF CANCER, 2020 VS. 2025
        • Table GLOBAL CANCER INCIDENCE, BY REGION, 2020 VS. 2025
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
    • PRICING ANALYSIS
      • AVERAGE SELLING PRICE OF MOLECULAR DIAGNOSTICS PRODUCTS, BY KEY PLAYER
        • Table AVERAGE SELLING PRICE OF MOLECULAR DIAGNOSTIC PRODUCTS
    • PATENT ANALYSIS
      • LIST OF MAJOR PATENTS
    • VALUE CHAIN ANALYSIS
    • SUPPLY CHAIN ANALYSIS
    • ECOSYSTEM/MARKET MAP ANALYSIS
      • MOLECULAR DIAGNOSTICS MARKET: ROLE IN ECOSYSTEM
    • PORTER'S FIVE FORCES ANALYSIS
      • Table MOLECULAR DIAGNOSTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
      • THREAT FROM NEW ENTRANTS
      • THREAT FROM SUBSTITUTES
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • INTENSITY OF COMPETITIVE RIVALRY
    • REGULATORY ANALYSIS
      • Table NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • Table ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • Table LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • Table REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • NORTH AMERICA
      • EUROPE
        • Table EUROPE: CLASSIFICATION OF DEVICES
      • ASIA PACIFIC
        • Table JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
      • LATIN AMERICA
      • MIDDLE EAST
      • AFRICA
    • TRADE ANALYSIS
      • TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
    • TECHNOLOGY ANALYSIS
    • KEY CONFERENCES AND EVENTS IN 2023-2024
      • Table MOLECULAR DIAGNOSTICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023-2024
    • PESTLE ANALYSIS
    • TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
      • REVENUE SHIFT IN MOLECULAR DIAGNOSTICS MARKET
    • KEY STAKEHOLDERS AND BUYING CRITERIA
      • KEY STAKEHOLDERS IN BUYING PROCESS
        • Table INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF MOLECULAR DIAGNOSTIC PRODUCTS (%)
      • BUYING CRITERIA
        • Table KEY BUYING CRITERIA FOR MOLECULAR DIAGNOSTIC PRODUCTS
    • CASE STUDY ANALYSIS
  • MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE
    • INTRODUCTION
      • Table MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
      • Table PRICE OF MOLECULAR DIAGNOSTIC PRODUCTS (2022)
    • REAGENTS & KITS
      • RECURRENT PURCHASES OF REAGENTS & KITS FOR DIAGNOSTIC ANALYSIS TO PROPEL MARKET
        • Table MOLECULAR DIAGNOSTICS MARKET FOR REAGENTS & KITS, BY REGION, 2021-2028 (USD MILLION)
    • INSTRUMENTS
      • INCREASING NEED FOR FASTER AND MORE ACCURATE TEST RESULTS TO BOOST MARKET
        • Table KEY INSTRUMENTS AVAILABLE IN GLOBAL MARKET
        • Table MOLECULAR DIAGNOSTICS MARKET FOR INSTRUMENTS, BY REGION, 2021-2028 (USD MILLION)
    • SERVICES & SOFTWARE
      • INCREASING UPTAKE OF ADVANCED INSTRUMENTS IN MOLECULAR DIAGNOSTICS MARKET TO DRIVE GROWTH
        • Table MOLECULAR DIAGNOSTICS MARKET FOR SERVICES & SOFTWARE, BY REGION, 2021-2028 (USD MILLION)
  • MOLECULAR DIAGNOSTICS MARKET, BY TEST TYPE
    • INTRODUCTION
      • Table MOLECULAR DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2028 (USD MILLION)
      • PRIMARY NOTES
    • LAB TESTS
      • ADVANCEMENTS IN DIAGNOSTIC TECHNOLOGIES AND INCREASED FOCUS ON EARLY DISEASE DETECTION TO DRIVE MARKET
        • Table MOLECULAR DIAGNOSTICS MARKET FOR LAB TESTS, BY REGION, 2021-2028 (USD MILLION)
    • POC TESTS
      • FASTER TURNAROUND TIME OF POC TESTS TO DRIVE SEGMENT GROWTH
        • Table MOLECULAR DIAGNOSTICS MARKET FOR POC TESTS, BY REGION, 2021-2028 (USD MILLION)
  • MOLECULAR DIAGNOSTICS MARKET, BY SAMPLE TYPE
    • INTRODUCTION
      • Table MOLECULAR DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2021-2028 (USD MILLION)
    • BLOOD, SERUM, AND PLASMA
      • UTILIZATION OF BLOOD SAMPLES IN DETECTING AND MANAGING INFECTIOUS DISEASES TO DRIVE MARKET
        • Table MOLECULAR DIAGNOSTICS MARKET FOR BLOOD, SERUM, AND PLASMA, BY REGION, 2021-2028 (USD MILLION)
    • URINE
      • NON-INVASIVE NATURE OF URINE SAMPLES TO FUEL SEGMENT GROWTH
        • Table MOLECULAR DIAGNOSTICS MARKET FOR URINE, BY REGION, 2021-2028 (USD MILLION)
    • OTHER SAMPLE TYPES
      • Table MOLECULAR DIAGNOSTICS MARKET FOR OTHER SAMPLE TYPES, BY REGION, 2021-2028 (USD MILLION)
  • MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY
    • INTRODUCTION
      • PRIMARY NOTES
        • Table MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • POLYMERASE CHAIN REACTION
      • GROWING USE OF POLYMERASE CHAIN REACTION IN PROTEOMICS AND GENOMICS TO DRIVE MARKET
        • Table MOLECULAR DIAGNOSTICS MARKET FOR POLYMERASE CHAIN REACTION, BY REGION, 2021-2028 (USD MILLION)
    • ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY
      • COST BENEFITS OF ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY IN NUCLEIC ACID SEQUENCING TO DRIVE MARKET
        • Table MOLECULAR DIAGNOSTICS MARKET FOR ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY REGION, 2021-2028 (USD MILLION)
    • DNA SEQUENCING & NEXT-GENERATION SEQUENCING
      • INCREASING USE OF NEXT-GENERATION SEQUENCING IN CANCER DIAGNOSIS TO FUEL MARKET
        • Table MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING & NEXT-GENERATION SEQUENCING, BY REGION, 2021-2028 (USD MILLION)
    • IN SITU HYBRIDIZATION
      • RISING PREVALENCE OF CANCER AND GENETIC DISORDERS TO DRIVE MARKET
        • Table MOLECULAR DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION, BY REGION, 2021- 2028 (USD MILLION)
    • DNA MICROARRAYS
      • INTRODUCTION OF DNA MICROARRAYS TO ACCELERATE GENE EXPRESSION AND DISEASE DIAGNOSIS
        • Table MOLECULAR DIAGNOSTICS MARKET FOR DNA MICROARRAYS, BY REGION, 2021-2028 (USD MILLION)
    • OTHER TECHNOLOGIES
      • Table MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021-2028 (USD MILLION)
  • MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION
    • INTRODUCTION
      • Table MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • INFECTIOUS DISEASE DIAGNOSTICS
      • Table MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2021-2028 (USD MILLION)
      • Table MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
      • HEPATITIS
        • Table HEPATITIS MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table HEPATITIS MARKET, BY REGION, 2021-2028 (MILLION TESTS)
      • HIV
        • Table HIV MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table HIV MARKET, BY REGION, 2021-2028 (MILLION TESTS)
      • CT/NG
        • Table CT/NG MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table CT/NG MARKET, BY REGION, 2021-2028 (MILLION TESTS)
      • HAIS
        • Table HAIS MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table HAIS MARKET, BY REGION, 2021-2028 (MILLION TESTS)
      • HPV
        • Table HPV MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table HPV MARKET, BY REGION, 2021-2028 (MILLION TESTS)
      • TUBERCULOSIS
        • Table TUBERCULOSIS MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table TUBERCULOSIS MARKET, BY REGION, 2021-2028 (MILLION TESTS)
      • INFLUENZA
        • Table INFLUENZA MARKET, BY REGION, 2021-2028 (USD MILLION)
        • Table INFLUENZA MARKET, BY REGION, 2021-2028 (MILLION TESTS)
      • OTHER INFECTIOUS DISEASES
        • Table OTHER INFECTIOUS DISEASES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • ONCOLOGY TESTING
      • Table MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2021-2028 (USD MILLION)
      • Table MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY REGION, 2021-2028 (USD MILLION)
      • BREAST CANCER
        • Table BREAST CANCER INCIDENCE, BY REGION, 2020 VS. 2040
        • Table BREAST CANCER MARKET, BY REGION, 2021-2028 (USD MILLION)
      • COLORECTAL CANCER
        • Table COLORECTAL CANCER MARKET, BY REGION, 2021-2028 (USD MILLION)
      • LUNG CANCER
        • Table LUNG CANCER MARKET, BY REGION, 2021-2028 (USD MILLION)
      • PROSTATE CANCER
        • Table PROSTATE CANCER MARKET, BY REGION, 2021-2028 (USD MILLION)
      • OTHER CANCERS
        • Table GLOBAL CANCER INCIDENCE, 2020
        • Table OTHER CANCERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • GENETIC TESTING
      • DIAGNOSIS OF VARIOUS DISEASES THROUGH GENETIC TESTING METHODS TO PROPEL MARKET
        • Table MOLECULAR DIAGNOSTICS MARKET FOR GENETIC TESTING, BY REGION, 2021-2028 (USD MILLION)
    • OTHER APPLICATIONS
      • Table MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • COVID-19
      • DECLINING CASES OF COVID-19 TO HINDER MARKET
        • Table MOLECULAR DIAGNOSTICS MARKET FOR COVID-19, BY REGION, 2021-2028 (USD MILLION)
  • MOLECULAR DIAGNOSTICS MARKET, BY END USER
    • INTRODUCTION
      • Table MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • DIAGNOSTIC LABORATORIES
      • INCREASED OUTSOURCING OF LABORATORY DIAGNOSES FOR REDUCTION IN COSTS TO DRIVE MARKET
        • Table MOLECULAR DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2021-2028 (USD MILLION)
    • HOSPITALS & CLINICS
      • GREATER NUMBER OF HOSPITALS AND HIGHER GOVERNMENT INVESTMENTS IN HEALTHCARE TO BOOST SEGMENT
        • Table MOLECULAR DIAGNOSTICS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2021-2028 (USD MILLION)
    • OTHER END USERS
      • Table MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)
  • MOLECULAR DIAGNOSTICS MARKET, BY REGION
    • INTRODUCTION
      • Table MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • IMPACT OF ECONOMIC RECESSION ON NORTH AMERICA
      • US
        • Table US: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table US: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table US: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table US: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
        • Table US: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2021-2028 (USD MILLION)
        • Table US: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • CANADA
        • Table CANADA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table CANADA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table CANADA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table CANADA: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • EUROPE
      • Table EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
      • Table EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2021-2028 (USD MILLION)
      • Table EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
      • Table EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
      • Table EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
      • Table EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2021-2028 (USD MILLION)
      • Table EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • IMPACT OF ECONOMIC RECESSION ON EUROPE
      • GERMANY
        • Table GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table GERMANY: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • UK
        • Table UK: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table UK: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table UK: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table UK: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
        • Table UK: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2021-2028 (USD MILLION)
        • Table UK: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • FRANCE
        • Table FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table FRANCE: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • ITALY
        • Table ITALY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table ITALY: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table ITALY: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table ITALY: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
        • Table ITALY: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2021-2028 (USD MILLION)
        • Table ITALY: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • SPAIN
        • Table SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table SPAIN: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
        • Table SPAIN: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2021-2028 (USD MILLION)
        • Table SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • RUSSIA
        • Table RUSSIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table RUSSIA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table RUSSIA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table RUSSIA: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
        • Table RUSSIA: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2021-2028 (USD MILLION)
        • Table RUSSIA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • REST OF EUROPE
        • Table REST OF EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • ASIA PACIFIC
      • Table ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • IMPACT OF ECONOMIC RECESSION ON ASIA PACIFIC
      • CHINA
        • Table CHINA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table CHINA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table CHINA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table CHINA: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • JAPAN
        • Table JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table JAPAN: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • INDIA
        • Table INDIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table INDIA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table INDIA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table INDIA: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
        • Table INDIA: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2021-2028 (USD MILLION)
        • Table INDIA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • AUSTRALIA
        • Table AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
        • Table AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2021-2028 (USD MILLION)
        • Table AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • REST OF ASIA PACIFIC
        • Table REST OF ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • LATIN AMERICA
      • Table LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
      • Table LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2021-2028 (USD MILLION)
      • Table LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
      • Table LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
      • Table LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
      • Table LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2021-2028 (USD MILLION)
      • Table LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • IMPACT OF ECONOMIC RECESSION ON LATIN AMERICA
      • BRAZIL
        • Table BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table BRAZIL: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
        • Table BRAZIL: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2021-2028 (USD MILLION)
        • Table BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • MEXICO
        • Table MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table MEXICO: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
        • Table MEXICO: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2021-2028 (USD MILLION)
        • Table MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • REST OF LATIN AMERICA
        • Table REST OF LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table REST OF LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table REST OF LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table REST OF LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • MIDDLE EAST & AFRICA
      • ADVANCEMENTS IN DIAGNOSTIC TECHNOLOGIES AND INCREASED HEALTHCARE INVESTMENTS TO PROPEL MARKET
        • Table MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY TYPE, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY TESTING, BY TYPE, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • IMPACT OF ECONOMIC RECESSION ON MIDDLE EAST & AFRICA
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • STRATEGIES ADOPTED BY KEY PLAYERS
      • OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN MOLECULAR DIAGNOSTICS MARKET
        • Table OVERVIEW OF STRATEGIES DEPLOYED BY KEY MOLECULAR DIAGNOSTIC MANUFACTURING COMPANIES
    • REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
    • MARKET SHARE ANALYSIS
      • Table MOLECULAR DIAGNOSTICS MARKET: DEGREE OF COMPETITION
      • MOLECULAR DIAGNOSTICS MARKET SHARE AND RANKING ANALYSIS, BY TECHNOLOGY
        • Table GLOBAL MOLECULAR DIAGNOSTICS MARKET RANKING FOR INAAT, BY KEY PLAYER, 2022
        • Table GLOBAL MOLECULAR DIAGNOSTICS MARKET RANKING FOR ISH, BY KEY PLAYER, 2022
      • MOLECULAR DIAGNOSTICS MARKET RANKING ANALYSIS, BY APPLICATION
        • Table GLOBAL MOLECULAR DIAGNOSTICS MARKET RANKING FOR INFECTIOUS DISEASES, BY KEY PLAYER, 2022
    • COMPANY EVALUATION MATRIX FOR KEY PLAYERS
      • LIST OF EVALUATED VENDORS
      • STARS
      • EMERGING LEADERS
      • PERVASIVE PLAYERS
      • PARTICIPANTS
    • COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022)
      • PROGRESSIVE COMPANIES
      • STARTING BLOCKS
      • RESPONSIVE COMPANIES
      • DYNAMIC COMPANIES
    • COMPETITIVE BENCHMARKING
      • PRODUCT AND GEOGRAPHICAL FOOTPRINT ANALYSIS
        • Table MOLECULAR DIAGNOSTICS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
        • Table COMPANY PRODUCT & SERVICE FOOTPRINT
        • Table COMPANY REGIONAL FOOTPRINT
        • Table MOLECULAR DIAGNOSTICS MARKET: DETAILED LIST OF KEY START-UPS/SMES
    • COMPETITIVE SCENARIO
      • KEY PRODUCT LAUNCHES
        • Table KEY PRODUCT LAUNCHES AND REGULATORY APPROVALS
      • KEY DEALS
        • Table KEY DEALS
  • COMPANY PROFILES
    • KEY PLAYERS
      • F. HOFFMANN-LA ROCHE LTD.
        • Table F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
      • HOLOGIC, INC.
        • Table HOLOGIC, INC.: COMPANY OVERVIEW
      • ABBOTT LABORATORIES
        • Table ABBOTT LABORATORIES: COMPANY OVERVIEW
      • BIOMÉRIEUX
        • Table BIOMÉRIEUX: COMPANY OVERVIEW
      • THERMO FISHER SCIENTIFIC INC.
        • Table THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
      • QIAGEN
        • Table QIAGEN: COMPANY OVERVIEW
      • PERKINELMER INC.
        • Table PERKINELMER INC.: COMPANY OVERVIEW
      • MYRIAD GENETICS, INC.
        • Table MYRIAD GENETICS, INC.: COMPANY OVERVIEW
      • SIEMENS HEALTHINEERS AG
        • Table SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
      • DANAHER
        • Table DANAHER: COMPANY OVERVIEW
    • OTHER PLAYERS
      • ILLUMINA, INC.
      • BECTON, DICKINSON AND COMPANY
      • GRIFOLS, S.A.
      • QUIDELORTHO CORPORATION
      • AGILENT TECHNOLOGIES, INC.
      • DIASORIN S.P.A.
      • EXACT SCIENCES CORPORATION
      • GENETIC SIGNATURES
      • MDXHEALTH
      • HTG MOLECULAR DIAGNOSTICS, INC.
      • BIOCARTIS
      • TBG DIAGNOSTICS LIMITED
        • Table TBG DIAGNOSTICS LIMITED: COMPANY OVERVIEW
      • VELA DIAGNOSTICS
        • Table VELA DIAGNOSTICS: COMPANY OVERVIEW
      • AMOY DIAGNOSTICS CO., LTD.
        • Table AMOY DIAGNOSTICS CO., LTD.: COMPANY OVERVIEW
      • ELITECHGROUP
        • Table ELITECHGROUP: COMPANY OVERVIEW
      • MOLBIO DIAGNOSTICS PVT. LTD.
        • Table MOLBIO DIAGNOSTICS PVT. LTD.: COMPANY OVERVIEW
      • SAVYON DIAGNOSTICS
        • Table SAVYON DIAGNOSTICS: COMPANY OVERVIEW
      • ABACUS DIAGNOSTICA OY
        • Table ABACUS DIAGNOSTICA OY.: COMPANY OVERVIEW
      • GENEOMBIO TECHNOLOGIES PVT. LTD.
        • Table GENEOMBIO TECHNOLOGIES PVT. LTD.: COMPANY OVERVIEW
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • CUSTOMIZATION OPTIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings